GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (OTCPK:ACHKF) » Definitions » Other Net Income (Loss)

Achiko AG (Achiko AG) Other Net Income (Loss) : $-0.00 Mil (TTM As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Achiko AG Other Net Income (Loss)?

Achiko AG's Other Net Income (Loss) for the six months ended in Jun. 2022 was $0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2022 was $-0.00 Mil.

Achiko AG's quarterly Other Net Income (Loss) declined from Jun. 2021 ($0.00 Mil) to Dec. 2021 ($-0.00 Mil) but then increased from Dec. 2021 ($-0.00 Mil) to Jun. 2022 ($0.00 Mil).


Achiko AG Other Net Income (Loss) Historical Data

The historical data trend for Achiko AG's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Other Net Income (Loss) Chart

Achiko AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21
Other Net Income (Loss)
- - - -

Achiko AG Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Other Net Income (Loss) Get a 7-Day Free Trial - - - - -

Achiko AG Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Achiko AG Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Achiko AG's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Achiko AG (Achiko AG) Business Description

Traded in Other Exchanges
N/A
Address
Tessinerplatz 7, Zurich, CHE, CH-8002
Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.

Achiko AG (Achiko AG) Headlines

From GuruFocus

Achiko AG Production and Sales Update

By Tiesvg Tiesvg 12-21-2022

Achiko AG � Suspension of Trading

By GuruFocusNews GuruFocusNews 07-08-2022

Achiko AG � Suspension of Trading

By GuruFocusNews GuruFocusNews 06-28-2022

Achiko AG Obtains CE Mark for AptameX� Covid-19 Rapid Test

By GuruFocusNews GuruFocusNews 06-26-2022

Achiko AG Production and Company Update

By Value_Insider Value_Insider 11-02-2022